Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -510 | -1,930 | -1,580 | -1,100 | -500 |
| Depreciation Amortization | 5 | 20 | 10 | 10 | 5 |
| Other Working Capital | 0 | -170 | -50 | 140 | 5 |
| Other Operating Activity | -5 | 770 | 650 | 550 | 160 |
| Operating Cash Flow | $-510 | $-1,310 | $-970 | $-400 | $-330 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -20 | -10 | -10 | 0 |
| Other Investing Activity | 51 | -4,060 | -120 | -70 | -30 |
| Investing Cash Flow | $50 | $-4,080 | $-130 | $-80 | $-30 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10 | 6,170 | 4,580 | 3,280 | 400 |
| Financing Cash Flow | $10 | $6,170 | $4,580 | $3,280 | $400 |
| Beginning Cash Position | 790 | 10 | 10 | 10 | 10 |
| End Cash Position | 350 | 790 | 3,480 | 2,810 | 30 |
| Net Cash Flow | $-440 | $780 | $3,470 | $2,800 | $20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -510 | -1,310 | -970 | -400 | -330 |
| Free Cash Flow | -510 | -1,310 | -970 | -400 | -330 |